Laurus Labs Ltd.
http://www.lauruslabs.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Laurus Labs Ltd.
Alphabet To AI Connect, What Favors Drug Development At Indian Institutes Of Technology
After starring in India’s first CAR-T treatment, the country’s Indian Institutes of Technology, or IITs, are set to expand their drug development footprint. Scrip takes a look at what the Indian equivalents of the Massachusetts Institute of Technology have going for them, including sizeable funding and alumni like Alphabet's CEO.
Krka To Plant Its Flag In India With Laurus Labs JV
Delivering record annual sales and profits according to preliminary financial results, Slovenia’s Krka will soon look to set up shop in India via a new company established with local big player Laurus Labs.
Transformative Innovation: How India Can Up Its Game, Big Pharma GCCs Add Value
A new report discusses the priorities that India should focus on to leapfrog towards transformative innovation. Big pharma’s expanding global capability centres (GCCs) in India are also contributing to the innovation ecosystem while positioning the country as the global industry's “backbone”.
India's ImmunoACT Gears To Deliver CAR-T Therapy At Close To Transplant-Like Prices
ImmunoACT gets go-ahead in India for its CD19-targeted CAR-T cell therapy, which reported low toxicity and the absence of neurotoxicities in clinical trials. The product will come at a huge price differential compared to on-market therapies, offering new hope to several patients.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice